Dx&Vx Signs Two Material Transfer Agreements in Latin America Within Two Months -- "Technology Validated Across Both Public and Private Sectors"
— Argentine biopharmaceutical company in July, South American public health institution in August sign consecutive KRNA material transfer agreements — Two of five cumulative MTAs now in Latin America, as company accelerates entry into the region's...
Dx&Vx (DXVX) Partners with Over 40 Global Companies at BIO USA, "Focused Discussions on Overseas Out-Licensing Deals"
Oral obesity drug with world-first mechanism of action unveiled, drawing strong on-site interest Following successful Phase 1 clinical results, global discussions on OVM-200 expand Meetings with over 40 companies, including major pharmaceutical...